XML 60 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 1 year 3 months 18 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 4,686,659
Number of grants, issued | shares 146,401
Number of grants, forfeited | shares (6,600)
Number of units, grant outstanding ending balance | shares 4,826,460
Number of grants, vested | shares 2,207,644
Number of grants, unvested | shares 2,618,816
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 13.61
Weighted average exercise price, grants issued | $ / shares 15.81
Weighted average exercise price, forefeited | $ / shares 16.02
Weighted average exercise price, grant outstanding ending balance | $ / shares 13.67
Weighted average exercise price, grants vested | $ / shares 13.68
Weighted average exercise price, grants unvested | $ / shares $ 13.66
Weighted Average Remaining Contractual Term, Grants Outstanding 7 years 7 months 6 days
Weighted Average Remaining Contractual Term, Grants Vested 7 years 3 months 18 days
Aggregate Intrinsic Value, grants outstanding | $ $ 12.3
Aggregate Intrinsic Value, grants vested | $ $ 5.6
First Advantage Corporation [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 1,915,252
Number of grants, exercised | shares (48,911)
Number of grants, forfeited | shares (16,978)
Number of units, grant outstanding ending balance | shares 1,849,363
Number of grants, vested | shares 823,589
Number of grants, unvested | shares 1,025,774
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 5.15
Weighted average exercise price, grants issued | $ / shares 5.48
Weighted average exercise price, forefeited | $ / shares 5.11
Weighted average exercise price, grant outstanding ending balance | $ / shares 5.15
Weighted average exercise price, grants vested | $ / shares 5.12
Weighted average exercise price, grants unvested | $ / shares $ 5.18
Weighted Average Remaining Contractual Term, Grants Outstanding 5 years 10 months 24 days
Weighted Average Remaining Contractual Term, Grants Vested 5 years 10 months 24 days
Aggregate Intrinsic Value, grants outstanding | $ $ 20.5
Aggregate Intrinsic Value, grants vested | $ $ 9.1